Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults

Background: In adults aged ≥60 years, two doses of the herpes zoster subunit vaccine (HZ/su; 50 µg varicella-zoster virus glycoprotein E [gE] and AS01(B) Adjuvant System) elicited humoral and cell-mediated immune responses persisting for at least six years. We assessed immunogenicity nine years post...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Tino F., Volpe, Stephanie, Catteau, Gregory, Chlibek, Roman, David, Marie Pierre, Richardus, Jan Hendrik, Lal, Himal, Oostvogels, Lidia, Pauksens, Karlis, Ravault, Stephanie, Rombo, Lars, Sonder, Gerard, Smetana, Jan, Heineman, Thomas, Bastidas, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037441/
https://www.ncbi.nlm.nih.gov/pubmed/29461919
http://dx.doi.org/10.1080/21645515.2018.1442162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037441/
https://www.ncbi.nlm.nih.gov/pubmed/29461919
http://dx.doi.org/10.1080/21645515.2018.1442162

Ejemplares similares